Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-27 to 2024-10-25
Current total value of award: $5618.2
Description: 8510704587!MOXIFLOXACIN HYDROC